Evidence map›Paper›PMID 31844922›Full record

Trial reportUrolithiasis2020

When is the best time to perform external physical vibration lithecbole (EPVL) after retrograde intrarenal surgery (RIRS): a multi-center study based on randomized controlled trials.

Yifan Zhang, Changbao Xu, Youzhi Wang, Rongjiang Wang, Wenqi Wu, Jiakai Yan, Xiaojian Gu, Xuehua Chen, Xiang Wang, Zhangqun Ye and 1 more

Abstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Urolithiasis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Yifan ZhangDepartment of Urology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China.
Changbao XuDepartment of Urology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China. xcb1966@126.com.
Youzhi WangDepartment of Urology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China.
Rongjiang WangDepartment of Urology, The People's Hospital of Huzhou, Huzhou, China.
Wenqi WuGuangdong Key Laboratory of Urology, Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Jiakai YanDepartment of Urology, The People's Hospital of Huzhou, Huzhou, China.
Xiaojian GuDepartment of Urology, The Chinese Medicine Hospital of Jiangsu Province, Nanjing, China.
Xuehua ChenDepartment of Urology, The Chinese Medicine Hospital of Jiangsu Province, Nanjing, China.
Xiang WangDepartment of Urology, The Tongji Hospital of Huazhong Science and Technology University, Wuhan, China.
Zhangqun YeDepartment of Urology, The Tongji Hospital of Huazhong Science and Technology University, Wuhan, China.
Guohua ZengGuangdong Key Laboratory of Urology, Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Second Affiliated Hospital of Zhengzhou University · CNFirst Affiliated Hospital of Guangzhou Medical University · CNJiangsu Province Hospital · CNThird People's Hospital of Huzhou · CNTongji Hospital · CN

Funding

L02 162300410295
6 · The paper itself

Abstract

To determine the best time to perform EPVL treatment by evaluating the efficacy and safety of active stone extraction in treating residual fragments at different time points after RIRS. All participants had renal or upper ureteral stones preoperatively and still had residual stones after receiving RIRS. They were prospectively randomized into four groups: patients in group A received EPVL 3 days after RIRS; patients in group B received EPVL 7 days after RIRS; patients in group C received EPVL 14 days after RIRS; patients in group D did not receive EPVL after RIRS. Follow-up examinations were performed on all participants. The results, including stone size and location, stone-free rate (SFR) and complications, were compared among the groups. There were 176 patients in total. The SFR in groups A, B, C and D were 62.22%, 40.91%, 14.28% and 11.11%, respectively, 7 days after RIRS. At 14 days after RIRS, the SFR was 80%, 59.09%, 42.86% and 26.67% in groups A, B, C and D, respectively. At 28 days after RIRS, the SFR was 91.11%, 84.09%, 76.19% and 51.11% in groups A, B, C and D, respectively. Group A had the highest SFR from 7 to 28 days, and group C had a higher SFR at 28 days after RIRS than group D (P < 0.05). The side effects were less in groups A and B than in group D 28 days after RIRS (P < 0.05). We recommended that the best time to perform EPVL is 3 days after RIRS, because it could achieve a high SFR at any point in time and reduced complications.

Indexed as

AdultFemaleHumansKidney CalculiMaleMiddle AgedPhysical Therapy ModalitiesProspective StudiesTime FactorsUreteral CalculiVibrationActive stone extractionExternal physical vibration lithecboleResidual stoneRetrograde intrarenal surgery

Identifiers

PMID31844922
OpenAlexW2995137384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.